This document discusses the diagnosis of hepatocellular carcinoma (HCC) through clinical presentation, investigations including imaging tests, tumor markers, viral markers, and liver biopsy. It describes the stages of HCC seen on MRI and the Okuda and Child-Turcotte-Pugh staging systems. Screening for HCC is recommended every 6 months for at-risk patients using AFP levels and ultrasound to detect HCC at treatable, asymptomatic stages.
This document discusses the diagnosis of hepatocellular carcinoma (HCC) through clinical presentation, investigations including imaging tests, tumor markers, viral markers, and liver biopsy. It describes the stages of HCC seen on MRI and the Okuda and Child-Turcotte-Pugh staging systems. Screening for HCC is recommended every 6 months for at-risk patients using AFP levels and ultrasound to detect HCC at treatable, asymptomatic stages.
This document discusses the diagnosis of hepatocellular carcinoma (HCC) through clinical presentation, investigations including imaging tests, tumor markers, viral markers, and liver biopsy. It describes the stages of HCC seen on MRI and the Okuda and Child-Turcotte-Pugh staging systems. Screening for HCC is recommended every 6 months for at-risk patients using AFP levels and ultrasound to detect HCC at treatable, asymptomatic stages.
• Presentasi klinis • Investigation • Staging 1. Investigation • Imaging : • Tumor marker - AFP measurement - Ultrasonography - Viral marker - CT Scan • Liver radio isotope scans - MRI • Liver function test • Liver Biopsy : - Serum bilirubin - AST - percutaneous aspiration or core - ALT biopsy - ALP - Prothrombin time - Serum albumin Alur penegakan diagnosa Studi MRI menunjukkan gambaran HCC pada beberapa stage A. Very early stage, (1 lesi 1.7cm), B. Early stage (2 lesi 2.4 dan 1.2cm) C. Intermediate stage (lesi multiple) D. Advanced (massa yang besar dan asites) 2. Staging : OKUDA staging system